Page last updated: 2024-12-06

tetramethylolphosphonium chloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tetramethylolphosphonium chloride: Negwer,5th ed has a number for a different cpd named THPC [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID31298
CHEMBL ID2131547
SCHEMBL ID196471
MeSH IDM0063669

Synonyms (52)

Synonym
EN300-19000
nsc 30698
proban cc
einecs 204-707-7
hsdb 2923
ai3-22268
tetrahydroxymethylphosphonium chloride
retardol c
phosphonium, tetrakis(hydroxymethyl)-, chloride
ccris 317
tetrakis-(hydroxymethyl)fosfoniumchlorid [czech]
pyroset tkc
wln: q1p1q1q1q & g
nci-c55061
124-64-1
nsc-30698
tetrakis(hydroxymethyl)phosphonium chloride
tetra(hydroxymethyl)phosphonium chloride
thpc
tetramethylolphosphonium chloride
nsc30698
tetrakis(hydroxymethyl)phosphochloride
phosphonium, chloro-tetrakis(hydroxymethyl)-
NCGC00164162-01
T0607
tetrakis(hydroxymethyl)phosphanium chloride
tox21_302070
dtxcid601330
cas-124-64-1
dtxsid5021330 ,
NCGC00255382-01
AKOS015918384
tetrakis-(hydroxymethyl)fosfoniumchlorid
58wb2xcf8i ,
unii-58wb2xcf8i
ec 204-707-7
phosphonium, tetrakis(hydroxymethyl)-, chloride (1:1)
FT-0631726
tetramethylolphosphonium chloride [hsdb]
tetrakis-(hydroxymethyl)phosphonium chloride
AKXUUJCMWZFYMV-UHFFFAOYSA-M
SCHEMBL196471
CHEMBL2131547
mfcd00031687
Q7706566
tetrakis(hydroxymethyl)phosphanium;chloride
tetrakis(hydroxymethyl)phosphonium chloride (ca. 80% in water)
CS-0214749
tetrakis(hydroxymethyl) posphonium chloride; thpc
F71160
thpc solution
tetrakis(hydroxymethyl)phosphonium chloride solution

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The data obtained were processed with PK-GRAPH pharmacokinetic procedure."( [Pharmacokinetics of photosensitizer m-THPC in rat models of liver cancer via orthotropic implantation using Walker-256].
Luo, FH; Quan, ZW; Shen, J; Wang, JD; Wang, SY; Yan, JH; Yang, D; Zhou, XP, 2011
)
0.37

Dosage Studied

ExcerptRelevanceReference
" The dose-response stability and preirradiation-induced variations in R2, related to the time interval between preparation and irradiation of the polymer gel, were investigated."( Basic investigations on the performance of a normoxic polymer gel with tetrakis-hydroxy-methyl-phosphonium chloride as an oxygen scavenger: reproducibility, accuracy, stability, and dose rate dependence.
Bayreder, C; Berg, A; Georg, D; Moser, E, 2006
)
0.33
" The results indicated that the dose-response (R2) of AMPS/Bis had a linear trend over a wide dose range."( Characteristics of a novel polymer gel dosimeter formula for MRI scanning: Dosimetry, toxicity and temporal stability of response.
Abtahi, SM, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency76.95880.000221.22318,912.5098AID1259243
progesterone receptorHomo sapiens (human)Potency2.73060.000417.946075.1148AID1346784
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency76.95880.001530.607315,848.9004AID1224841; AID1259401
pregnane X nuclear receptorHomo sapiens (human)Potency69.69210.005428.02631,258.9301AID1346982; AID720659
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency5.49410.001019.414170.9645AID743191
activating transcription factor 6Homo sapiens (human)Potency3.36290.143427.612159.8106AID1159516; AID1159519
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency29.78960.000627.21521,122.0200AID651741; AID720636; AID743202; AID743219
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency61.13060.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency61.13060.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (18)

Processvia Protein(s)Taxonomy
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (10)

Processvia Protein(s)Taxonomy
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (7.14)18.7374
1990's5 (17.86)18.2507
2000's8 (28.57)29.6817
2010's12 (42.86)24.3611
2020's1 (3.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.53 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index4.90 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]